No Data
Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) Stock Price Dropped 8.8% Last Week; Private Companies Would Not Be Happy
Lanwei Medical (301060.SZ): Zeng Weixiong was elected as the company's Director.
Gelonghui, December 16 - Lanwei Medical (301060.SZ) announced that, after being reviewed and approved by the Board of Directors, Mr. Zeng Weixiong was elected as the chairman of the company, with a term starting from the date of approval at the first meeting of the fourth Board of Directors until the end of the fourth Board of Directors' term.
Lan Wei Medical (301060.SZ): Hailan Group has cumulatively reduced its shareholding by 5%.
Lanwei Medical (301060.SZ) announced that shareholder Hailan Group Co., Ltd. (referred to as "Hailan Group") from...
November 13th A-share Investment Lightning Rod: Bona Film Group - several shareholders plan to reduce their shareholding by no more than 3.9754%; Ningbo Runhe High-Tech Materials - shareholders plan to jointly reduce their shareholding by no more than 2.0
Bona Film Group's multiple shareholders plan to reduce their shareholding by no more than 3.9754%; Ningbo Runhe High-Tech Materials' shareholders plan to collectively reduce their shareholding by no more than 2.00%; Lanwei Medical's shareholder, Ocean Wide Holdings Group, plans to reduce their shareholding by no more than 2%; Shanghai Sunglow Packaging Technology indicates additional investment in jintaike involves new business areas with uncertain expected returns; Zhengping Road & Bridge Construction received a warning letter from the Qinghai Regulatory Bureau of the CSRC; AsiaInfo Security received a warning letter from the Jiangsu Regulatory Bureau.
Lanwei Medical (301060.SZ): has repurchased 0.50% of the shares.
Grain Stockpile November 1st丨Lanwei Medical (301060.SZ) announced, as of October 31, 2024, the company repurchased a total of 1,996,100 shares of the company through the Shenzhen Stock Exchange stock trading system through centralized competitive bidding trading, accounting for 0.50% of the current total share capital of the company. The highest fill price was 14.23 yuan/share, the lowest fill price was 8.12 yuan/share, and the total fill amount was RMB 23.0046 million yuan (excluding transaction fees).
Lanwei Medical: Report for the third quarter of 2024
Investors Give Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) Shares A 27% Hiding
